Literature DB >> 12635003

Effects of inhaled CdO particles on the sphingolipid synthesis of rat lungs.

F Alessandrini1, A Ziesenis, S Takenaka, E Karg, J Heyder, J Ring, H Behrendt.   

Abstract

Surfactant lipids of the alveolar space protect the lung from various environmental stimuli. We investigated the influence of ultrafine (UF) CdO particles inhalation on two key enzymes involved in lung sphingolipid metabolism, serine palmitoyltransferase (SPT), and sphingomyelinase (SMase). Rats inhaled either 0.63 mg UF-CdO/m(3) for 6 h (group 1), or 1.08 mg UF-CdO/m(3) 12 h/day for 10 days (group 2). Two corresponding control groups inhaled filtered clean air. Additional rats intratracheally instilled with lipopolysaccharide (LPS) were used as positive controls. Semiquantitative reverse-transcription polymerase chain reaction (RT-PCR) of lung tissue showed a significant increase in the level of SPT mRNA (LCB2 subunit) expression in group 2 compared to the corresponding controls (p <.01). Group 1 and LPS were not statistically different from control. No alteration in the mRNA level of SMase was detected in any exposure group. The immunohistochemical analysis showed that SPT (LCB2 subunit) localization was stronger in the alveolar type II cells of group 2 lungs compared to the corresponding controls. These results were correlated with alterations in BALF cellular and biochemical parameters and lung morphology. Since SPT is the key enzyme for de novo sphingolipid synthesis in lung surfactant and SMase is responsible for sphingomyelin catabolism, we can postulate that high-dose UF-CdO exposure for 10 days induces an increase in sphingolipid synthesis in the type II cells of rat lungs that would not be promptly followed by its degradation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12635003     DOI: 10.1080/08958370304457

Source DB:  PubMed          Journal:  Inhal Toxicol        ISSN: 0895-8378            Impact factor:   2.724


  4 in total

1.  Impact of acute and chronic inhalation exposure to CdO nanoparticles on mice.

Authors:  J Lebedová; L Bláhová; Z Večeřa; P Mikuška; B Dočekal; M Buchtová; I Míšek; J Dumková; A Hampl; K Hilscherová
Journal:  Environ Sci Pollut Res Int       Date:  2016-09-16       Impact factor: 4.223

2.  Short-term inhalation of cadmium oxide nanoparticles alters pulmonary dynamics associated with lung injury, inflammation, and repair in a mouse model.

Authors:  Jason L Blum; Lauren K Rosenblum; Gabriele Grunig; Mary Beth Beasley; Judy Q Xiong; Judith T Zelikoff
Journal:  Inhal Toxicol       Date:  2014-01       Impact factor: 2.724

3.  Ultrafine particles affect the balance of endogenous pro- and anti-inflammatory lipid mediators in the lung: in-vitro and in-vivo studies.

Authors:  Ingrid Beck-Speier; Erwin Karg; Heidrun Behrendt; Tobias Stoeger; Francesca Alessandrini
Journal:  Part Fibre Toxicol       Date:  2012-07-18       Impact factor: 9.400

4.  Pulmonary effects of inhalation of spark-generated silver nanoparticles in Brown-Norway and Sprague-Dawley rats.

Authors:  Joanna Seiffert; Alison Buckley; Bey Leo; Nicholas G Martin; Jie Zhu; Ranran Dai; Farhana Hussain; Chang Guo; James Warren; Alan Hodgson; Jicheng Gong; Mary P Ryan; Junfeng Jim Zhang; Alexandra Porter; Terry D Tetley; Andrew Gow; Rachel Smith; Kian Fan Chung
Journal:  Respir Res       Date:  2016-07-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.